Topic 5.2
Tomorrow.bio advantage
Cryopreservation quality is decided in the field, in the hours after legal death, and by the institutions that have to keep working for decades afterwards. This topic exists to explain what Tomorrow.bio has built around that fact: a European response operation with whole-body field cryoprotection, standardized quality measurement for every patient, a Swiss long-term storage facility run by a separate foundation, engineering that starts from real cases, and research that keeps today's procedures and tomorrow's revival work clearly apart. It also covers the founders, the membership model and what happens step by step when a member needs us. The goal is to let you judge the organization on evidence rather than on claims.
A brief history of Tomorrow.bioTomorrow.bio was founded in 2020 and built a European cryopreservation operation, a Swiss storage facility and a three-organisation patient-care structure before expanding to the continental United States.Why Tomorrow.bio’s preservation quality is unmatchedTomorrow.bio combines whole-body field cryoprotection, detailed case data, controlled cooldown, standardized cryogenic CT for every patient, public reports and developing ultrastructural analysis. We believe this is the most complete and measurable human cryopreservation programme in the world.The foundersEmil Kendziorra and Fernando Azevedo Pinheiro brought complementary medical, scientific, engineering and operational experience to Tomorrow.bio. Their real legacy is the institution they are building to outlast them.The vision of Tomorrow.bio membershipTomorrow.bio membership is designed as a lifelong relationship: preservation readiness, practical lifespan support, member connections, and continued investment in better cryopreservation.Lifespan extension’s backup planTomorrow.bio's Lifespan Extension Program gives members expert longevity support while cryopreservation remains ready as a backup and revival research moves forward.Applied engineeringApplied engineering at Tomorrow.bio starts with constraints and failures from real cases, then turns them into better mobile equipment, monitoring and procedures for the next patient.What actually happens when you need us?When a member enters a critical condition, early notification lets Tomorrow.bio coordinate standby, the medical procedure, paperwork, transport, quality review and transfer into long-term care.Research and development initiativesTomorrow.bio improves today’s cryopreservation procedures while testing the harder technologies needed for future revival, with deployed systems, active trials and long-term goals clearly separated.